Besides PPARA, there are multiple genes that have been identified to play roles in the survival of CLL B cells and were suggested as therapeutic targets in CLL, including NOTCH [13, 14], ZAP70 [15], CXCR4 [16], CD40 [17], CD44, and CD49d [18]. Here, CD44 is linked to B-cell chronic lymphocytic leukemia.